BRAF V600 MUTATION
Clinical trials for BRAF V600 MUTATION explained in plain language.
Never miss a new study
Get alerted when new BRAF V600 MUTATION trials appear
Sign up with your email to follow new studies for BRAF V600 MUTATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Targeted attack on tough colon cancer before surgery
Disease control CompletedThis study tested a combination of three targeted drugs (encorafenib, binimetinib, and cetuximab) given for 8 weeks before surgery to people with a specific genetic type of localized colon cancer (BRAF V600E mutated). The goal was to see if this 'neoadjuvant' approach could shrin…
Matched conditions: BRAF V600 MUTATION
Phase: PHASE2 • Sponsor: AIO-Studien-gGmbH • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC
-
App tracks life with advanced melanoma
Knowledge-focused CompletedThis study observed 400 adults in Europe with advanced, hard-to-treat skin cancer (melanoma) who were already receiving standard targeted drug therapy. The goal was to learn about these patients and understand how they used a specific mobile app (TavieSkin) designed to support th…
Matched conditions: BRAF V600 MUTATION
Sponsor: Pierre Fabre Medicament • Aim: Knowledge-focused
Last updated Mar 24, 2026 12:02 UTC